Abstract
The Future Revascularization Evaluation in Patients With Diabetes Mellitus: Optimal Management of Multivessel Disease (FREEDOM) trial (N Engl J Med 2012; 367:2375-2384) was designed to resolve the long-standing debate over the optimal revascularization strategy in patients with diabetes mellitus and multivessel coronary artery disease. At a median follow-up of 3.8 years, the incidence of the primary outcome (a composite of death, myocardial infarction, and stroke) was significantly lower with bypass surgery than with percutaneous intervention.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 515-523 |
| Number of pages | 9 |
| Journal | Cleveland Clinic journal of medicine |
| Volume | 80 |
| Issue number | 8 |
| DOIs | |
| State | Published - 2013 |
ASJC Scopus subject areas
- General Medicine
Fingerprint
Dive into the research topics of 'The freedom trial: In appropriate patients with diabetes and multivessel coronary artery disease, CABG beats PCI'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS